Fulgent Genetics (FLGT) Assets Average (2016 - 2026)

Fulgent Genetics (FLGT) has 11 years of Assets Average data on file, last reported at $1.2 billion in Q1 2026.

• Quarterly Assets Average fell 2.3% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 2.3% YoY) and the FY2025 annual result came in at $1.2 billion, down 0.89% from the prior year.
• Assets Average eased to $1.2 billion in Q1 2026 per FLGT's latest filing, from $1.2 billion in the prior quarter.
• The five-year high for Assets Average was $1.5 billion in Q2 2022, with the low at $735.0 million in Q1 2023.
• Average Assets Average over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
• The widest YoY moves for Assets Average: up 73.03% in 2023, down 46.43% in 2023.
• Fulgent Genetics' Assets Average stood at $749.5 million in 2022, then jumped by 73.03% to $1.3 billion in 2023, then dropped by 5.4% to $1.2 billion in 2024, then slipped by 1.04% to $1.2 billion in 2025, then retreated by 2.4% to $1.2 billion in 2026.
• Business Quant data shows FLGT's Assets Average at $1.2 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.